Global MRI Coils Market - 2025 - 2033

The global MRI coils market reached US$ 9.26 billion in 2024 and is expected to reach US$ 18.18 billion by 2033, growing at a CAGR of 8.1% during the forecast period 2025-2033.

MRI coils are critical components of Magnetic Resonance Imaging (MRI) systems, enabling high-quality diagnostic images of diverse body areas. MRI coils are specialized devices that work similarly to antennas. They are made up of one or more loops of copper wire that help create and receive radiofrequency (RF) signals during an MRI scan. These coils are essential to the imaging process because they enable the capturing of signals released by the body's atomic nuclei when subjected to a strong magnetic field.

MRI coils receive RF signals created by the MRI machine and transmit them to a computer, where they are processed to provide detailed images of the body's internal architecture. Coils come in a variety of designs adapted to certain anatomical locations. Some coils are frame-like and fit over the area being scanned, but others are flexible and adjust to the body's shape.

Market Dynamics: Drivers & Restraints

Increasing demand for MRI coils

The increasing demand for MRI coils is expected to be a significant factor in the growth of the global MRI coils market. The global MRI coils market is poised for significant expansion, owing mostly to the increasing demand for diagnostic imaging procedures, the rising prevalence of chronic diseases, technological advancements, and new product launches and approvals. Chronic diseases such as cardiovascular disorders, cancer, and neurological conditions are on the rise as a result of aging populations, lifestyle changes, and environmental influences.

For instance, according to the Centers for Disease Control and Prevention, around 20.1 Million adults age 20 and older have coronary artery disease, about 7.2% in the United States. According to the National Center for Biotechnology Information, 2023, Osteoporosis is the most common metabolic bone disorder globally and in tropical countries. The prevalence of osteoporosis is 30 to 50% among postmenopausal women and up to 20% in men above 50 years. Furthermore, according to the World Health Organization, 2023, diseases like cancers, chronic obstructive pulmonary diseases, asthma, diabetes, and cardiovascular diseases affect people in low- and middle-income countries, where more than three-quarters of global NCD deaths (31.4 million) occur that rounds up to 80%. Approximately 17 million people die from an NCD before age 70. The increasing prevalence of such disorders needs improved imaging techniques capable of providing deep insights into patients' health, making MRI a vital tool in modern medicine. As the prevalence of chronic diseases rises, healthcare organizations are progressively implementing MRI technologies to improve diagnostic accuracy and treatment planning.

The MRI coils market is also driven by the technical improvements that enhance the design and functionality of these devices. MRI scans are becoming more efficient and effective due to innovations including higher signal-to-noise ratios (SNRs) and faster scan times. As manufacturers create novel radiofrequency (RF) coils and gradient coils specialized to specific applications, image quality increases, which is critical for identifying complex chronic conditions. Furthermore, the incorporation of high-field MRI systems (such as 3T and 7T machines) improves imaging capabilities by allowing for crisper and more detailed pictures, which are critical in detecting subtle changes associated with chronic diseases.

For instance, in November 2023, Royal Philips, a global pioneer in health technology, launched three new MR Smart Fit coils that are ideal for their intended use. RF coils are a fundamental component of all MRI scans. The new ultra-lightweight coils offer remarkable flexibility, a significant reduction in patient setup time, and optimization with Philips' SmartSpeed AI solution, resulting in higher image quality resolution and increased diagnostic confidence for healthcare practitioners.

High costs of devices

Factors such as high costs of devices are expected to hamper the global MRI coils market. The cost of purchasing and maintaining MRI coils can be high, particularly for healthcare facilities in underdeveloped countries where funds are limited. The cost of MRI coils varies greatly, with new equipment ranging from USD 12,000 to $120,000. In comparison, reconditioned coils are more affordable but still require a significant investment, ranging from USD 3,000 to USD 25,000. These expenses can slow the adoption of new technologies, especially in developing countries where healthcare financing is limited and financial restraints are common. As a result, many hospitals may choose to employ older equipment or refurbished coils rather than invest in the most recent technology, resulting in inequalities in diagnostic capabilities between regions.

Segment Analysis

The global MRI coils market is segmented based on coil type, application, end-user, and region.

Radiofrequency Coils segment is expected to dominate the global MRI coils market share

The radiofrequency coils segment is anticipated to dominate the global MRI coils market owing to its critical role in the MRI imaging process and the increasing demand for advanced diagnostic technologies. RF coils are critical components of MRI systems, serving as both transmitters and receivers of radiofrequency signals. This dual functionality enables them to produce high-quality images of inside body structures, making them valuable in medical diagnostics.

The increased preference for non-invasive diagnostic procedures contributes to the dominance of RF coils in the MRI market. Patients increasingly prefer imaging procedures that reduce inconvenience and risk while delivering detailed information about their health issues. As a result, hospitals are investing in advanced MRI systems equipped with high-quality RF coils to meet demand. The incorporation of artificial intelligence (AI) and machine learning into MRI technology is also expected to boost the capabilities of RF coils, confirming their role in current medical diagnosis.

Continuous advances in RF coil technology are strengthening their market position. Innovations include lighter and more flexible designs that improve patient comfort during scans while also increasing imaging procedure efficiency. These advancements not only improve imaging quality but also contribute to faster diagnosis and treatment planning, which is critical for efficient chronic disease management. For instance, in May 2024, a team of scientists from the German Cancer Research Center, designed an RF coil with minimal ion attenuation, based on a cylindrical 16-rung birdcage configuration. This specific birdcage coil only has capacitors on the end rings, thereby avoiding attenuation and scattering in a large window in between. The RF coil is designed to prevent adverse effects such as ion attenuation and scattering that are caused due to highly attenuating electronic components which alter the delivered dose distribution and reduce treatment efficacy.

Geographical Analysis

North America is expected to hold a significant position in the global MRI coils market share

North America will likely account for a significant share of the global MRI coils market, owing to its advanced healthcare infrastructure, increasing prevalence of chronic diseases, and substantial investments in medical technology, technological advancements, and recent launches and approvals. The rising incidence of chronic diseases has a substantial influence on healthcare services in North America. As healthcare practitioners work to enhance early diagnosis and treatment results, demand for MRI services has increased. This development is especially noticeable in hospitals and diagnostic imaging centers, which are increasingly using powerful MRI systems with complex coils. These coils serve an important role in improving image quality and delivering specific information about the medical conditions of patients.

For instance, according to an article published by the National Institute of Health, in 2024, 2,001,140 new cancer cases and 611,720 cancer deaths are projected to occur in the United States. Cancer mortality continued to decline through 2021, averting over 4 million deaths since 1991 because of reductions in smoking, earlier detection for some cancers, and improved treatment options in both adjuvant and metastatic settings. However, these gains are threatened by increasing incidence for 6 of the top 10 cancers.

The region's healthcare sector is highlighted by significant financial investments in new medical technologies, which has a direct impact on demand for MRI coils. These investments not only increase the availability of new diagnostic technologies but also ensure that healthcare facilities can meet the growing demand for imaging services. As hospitals and diagnostic centers strive to improve patient outcomes through early identification and intervention, they are increasingly relying on modern MRI systems with revolutionary coil technologies. This pattern is additionally facilitated by North America's high levels of healthcare spending, which make it easier to purchase advanced MRI equipment with sophisticated coils.

For instance, in June 2024, Promaxo, a developer of portable low-field MRI systems and minimally invasive robotics, received an investment from Zynext Ventures, the Venture Capital (VC) arm of Zydus Lifesciences. The investment from Zynext Ventures will enable Promaxo to expand its operations and accelerate development efforts in the field of advanced MRI technology.

Asia Pacific is growing at the fastest pace in the global MRI coils market

The Asia Pacific region is emerging as the fastest-growing market for MRI coils, owing to a combination of demographic trends, increased healthcare investment, recent launches, and a rising number of chronic diseases. The rising frequency of chronic diseases in the region of Asia-Pacific has increased the need for appropriate diagnostic imaging solutions. Cardiovascular diseases, cancer, and neurological disorders are becoming increasingly common, necessitating the use of modern imaging tools to accurately diagnose and plan treatments. The increased awareness of early diagnosis among patients and healthcare providers is driving up demand for MRI systems, which rely on high-quality coils to produce precise imaging results.

For instance, according to the National Institute of Health, the estimated number of incident cases of cancer in India for the year 2022 was found to be 14,61,427 (crude rate:100.4 per 100,000). In India, one in nine people is likely to develop cancer in his/her lifetime. Lung and breast cancers were the leading sites of cancer in males and females, respectively. Among the childhood (0-14 yr) cancers, lymphoid leukemia (boys: 29.2% and girls: 24.2%) was the leading site. The incidence of cancer cases is estimated to increase by 12.8 percent in 2025 as compared to 2020.

Competitive Landscape

The major global players in the global MRI coils market include GE HealthCare, Koninklijke Philips N.V, Siemens Healthcare Private Limited, Canon Medical Systems, Esaote SPA, MR Instruments, Inc., RAPID MR International, ScanMed, LLC, Bruker, Tesla Engineering Ltd among others.

Emerging Players

Innovatus Imaging and Time Medical Holding Co Ltd among others

Key Developments

• In November 2024, Polarean Imaging PLC received FDA 510(k) clearance for its XENOVIEW 3T chest coil to be used with GE HealthCare 3 Tesla (3T) MRI systems. The clearance allows the use of the device to support lung imaging using hyperpolarised Xenon-129 for oral inhalation in adults and children aged 12 and older. It works with GE MRI models, including the SIGNA Premier 3T and Discovery MR750 3T, equipped with multi-nuclear spectroscopy.
• In May 2024, Siemens Healthineers invested 250 million pounds ($314 million) in a facility to establish a new MRI manufacturing plant in the U.K.

Why Purchase the Report?

• Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
• Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
• Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
• Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
• Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
• Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
• Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
• Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
• Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
• Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
• Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
• Post-market Surveillance: Uses post-market data to enhance product safety and access.
• Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global MRI coils market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

• Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
• Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
• Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
• Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
• Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
• Supply Chain: Distribution and Supply Chain Managers.
• Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
• Academic & Research: Academic Institutions.